Clinical Trials Browser

Interventional × GDC-0084 × 30 days × Clear all

NCT03970447 2026-06-03

GBM AGILE

Phase 2/3 Recruiting

Glioblastoma, Recurrence

NCT03765983 2026-05-27

GDC-0084 in Combination With Trastuzumab for Patients With HER2-Positive Breast Cancer Brain Metastases

Phase 2 Terminated

17 enrolled 14 charts

Breast Neoplasms